189 related articles for article (PubMed ID: 20058233)
1. Nuclear inositide signaling in myelodysplastic syndromes.
Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
[TBL] [Abstract][Full Text] [Related]
2. Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.
Mongiorgi S; Follo MY; Clissa C; Giardino R; Fini M; Manzoli L; Ramazzotti G; Fiume R; Finelli C; Cocco L
Curr Top Microbiol Immunol; 2012; 362():235-45. PubMed ID: 23086421
[TBL] [Abstract][Full Text] [Related]
3. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
[TBL] [Abstract][Full Text] [Related]
4. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
Cocco L; Manzoli L; Palka G; Martelli AM
Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
[TBL] [Abstract][Full Text] [Related]
5. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
[TBL] [Abstract][Full Text] [Related]
6. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
7. Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics.
Follo MY; Mongiorgi S; Finelli C; Piazzi M; Faenza I; Ramazzotti G; Santi P; McCubrey JA; Martelli AM; Cocco L
Curr Pharm Des; 2012; 18(13):1751-4. PubMed ID: 22352752
[TBL] [Abstract][Full Text] [Related]
8. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.
Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L
Adv Enzyme Regul; 2008; 48():2-9. PubMed ID: 18280812
[No Abstract] [Full Text] [Related]
9. Physiology and pathology of nuclear phospholipase C β1.
Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
[TBL] [Abstract][Full Text] [Related]
10. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
11. Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.
Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L
Adv Enzyme Regul; 2007; 47():2-9. PubMed ID: 17335878
[No Abstract] [Full Text] [Related]
12. Intranuclear 3'-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?
Martelli AM; Faenza I; Billi AM; Manzoli L; Evangelisti C; Falà F; Cocco L
Cell Signal; 2006 Aug; 18(8):1101-7. PubMed ID: 16516442
[TBL] [Abstract][Full Text] [Related]
13. Advances in MDS/AML and inositide signalling.
De Stefano A; Marvi MV; Fazio A; McCubrey JA; Suh PG; Ratti S; Ramazzotti G; Manzoli L; Cocco L; Follo MY
Adv Biol Regul; 2023 Jan; 87():100955. PubMed ID: 36706610
[TBL] [Abstract][Full Text] [Related]
14. Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes.
Mongiorgi S; Finelli C; Yang YR; Clissa C; McCubrey JA; Billi AM; Manzoli L; Suh PG; Cocco L; Follo MY
Expert Opin Ther Targets; 2016 Jun; 20(6):677-87. PubMed ID: 26610046
[TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus.
Fiume R; Teti G; Faenza I; Cocco L
Methods Mol Biol; 2010; 645():143-64. PubMed ID: 20645187
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.
Xian J; Owusu Obeng E; Ratti S; Rusciano I; Marvi MV; Fazio A; De Stefano A; Mongiorgi S; Cappellini A; Ramazzotti G; Manzoli L; Cocco L; Follo MY
Cells; 2020 Mar; 9(3):. PubMed ID: 32178280
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Inositide Signaling Via Phospholipase C.
Ratti S; Mongiorgi S; Ramazzotti G; Follo MY; Mariani GA; Suh PG; McCubrey JA; Cocco L; Manzoli L
J Cell Biochem; 2017 Aug; 118(8):1969-1978. PubMed ID: 28106288
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
[TBL] [Abstract][Full Text] [Related]
20. Nuclear phospholipase C: involvement in signal transduction.
Manzoli L; Martelli AM; Billi AM; Faenza I; Fiume R; Cocco L
Prog Lipid Res; 2005 Jul; 44(4):185-206. PubMed ID: 15896848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]